BTIG Research downgraded Organogenesis from Buy to Neutral
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/28/2024 | $5.00 | Buy | Lake Street |
| 2/7/2024 | $5.00 | Overweight | Cantor Fitzgerald |
| 6/15/2023 | $5.00 | Equal-Weight | Morgan Stanley |
| 5/24/2023 | $10.00 | Neutral → Buy | BTIG Research |
| 11/10/2022 | Buy → Neutral | BTIG Research | |
| 8/10/2022 | Outperform → Perform | Oppenheimer | |
| 11/10/2021 | $26.00 → $20.00 | Outperform | SVB Leerink |
| 8/10/2021 | $24.00 → $25.00 | Outperform | Credit Suisse |
4 - Organogenesis Holdings Inc. (0001661181) (Issuer)
DEF 14A - Organogenesis Holdings Inc. (0001661181) (Filer)
10-Q - Organogenesis Holdings Inc. (0001661181) (Filer)
8-K - Organogenesis Holdings Inc. (0001661181) (Filer)